BioCentury
ARTICLE | Clinical News

Topamax topiramate regulatory update

November 11, 2002 8:00 AM UTC

JNJ submitted an sNDA to the FDA for Topamax as a monotherapy to treat epilepsy. Topamax is approved outside the U.S. as monotherapy, and in the U.S. for use in combination with other anti-epileptic m...